Pharmacovigilance in China: issues of concern identified through an analysis of the Chinese Adverse Drug Reaction Information Bulletin 2001 to 2014.
- DOI
- 10.1111/jcpt.12317
- Published
- 2015-08-20
- Container
- J Clin Pharm Ther
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/jcpt.12317,
title = {Pharmacovigilance in China: issues of concern identified through an analysis of the Chinese Adverse Drug Reaction Information Bulletin 2001 to 2014.},
author = {Gao P and Zhang CL and Zeng FD and Pu R and Zhang J and Huang R and Liu D.},
year = {2015},
journal = {J Clin Pharm Ther},
doi = {10.1111/jcpt.12317},
url = {https://doi.org/10.1111/jcpt.12317}
}RIS
TY - JOUR TI - Pharmacovigilance in China: issues of concern identified through an analysis of the Chinese Adverse Drug Reaction Information Bulletin 2001 to 2014. AU - Gao P AU - Zhang CL AU - Zeng FD AU - Pu R AU - Zhang J AU - Huang R AU - Liu D. PY - 2015 JO - J Clin Pharm Ther DO - 10.1111/jcpt.12317 UR - https://doi.org/10.1111/jcpt.12317 ER -
APA
P, G., CL, Z., FD, Z., R, P., J, Z., R, H., & D., L. (2015). Pharmacovigilance in China: issues of concern identified through an analysis of the Chinese Adverse Drug Reaction Information Bulletin 2001 to 2014.. J Clin Pharm Ther. https://doi.org/10.1111/jcpt.12317
Source records
- europe-pmc · retrieved 2026-09-25T04:30:38.155Z